MedPath

Effectiveness Of Melatonin In Preventing Delirium In Critically Ill Patients

Not Applicable
Conditions
Health Condition 1: F05- Delirium due to known physiological condition
Registration Number
CTRI/2021/06/034425
Lead Sponsor
Dr Priyamvada Gupta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Critically ill patients Age >18 or < 70

2. Within the first 24 h of admission in the ICU

3.Anticipated ICU stay 5 days or more

4.No basic delirium or mood changes before admission in ICU

Exclusion Criteria

If they had less than 5 days of ICU stay

2. Sensitivity reaction to the melatonin supplement.

3. Pregnancy

4. Previous history of seizure or active seizure

5. ICU admission more than 24 hours at the time of screening

6. Unable to assess for delirium

7. History of severe cognitive or neurodegenerative disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath